These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33766910)

  • 21. Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease.
    Khanna R; Zou G; Stitt L; Feagan BG; Sandborn WJ; Rutgeerts P; McDonald JWD; Dubcenco E; Fogel R; Panaccione R; Jairath V; Nelson S; Shackelton LM; Huang B; Zhou Q; Robinson AM; Levesque BG; D'Haens G
    Am J Gastroenterol; 2017 Oct; 112(10):1584-1592. PubMed ID: 28071654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Correlation between contrast-enhanced ultrasound parameters and Crohn's disease activity].
    Zhang YY; Yuan T; Wang CW; Wang L; Zhang HJ; Wang YL
    Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):427-432. PubMed ID: 37032139
    [No Abstract]   [Full Text] [Related]  

  • 23. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
    Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J
    Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of pediatric Crohn's disease activity: validation of the magnetic resonance enterography global score (MEGS) against endoscopic activity score (SES-CD).
    Zheng X; Li M; Wu Y; Lin X; Zhang Z; Zheng W; Wang M
    Abdom Radiol (NY); 2020 Nov; 45(11):3653-3661. PubMed ID: 32458027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers.
    Stoppino LP; Della Valle N; Rizzi S; Cleopazzo E; Centola A; Iamele D; Bristogiannis C; Stoppino G; Vinci R; Macarini L
    BMC Med Imaging; 2016 May; 16(1):37. PubMed ID: 27149857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between endoscopic and histological validated scoring indices in Crohn's disease.
    Gong W; Guo K; Zheng T; Fang M; Xie H; Li W; Hong Z; Ren H; Gu G; Wang G; Wu X; Wang Z; Ren J; Li J
    Dig Liver Dis; 2019 Jun; 51(6):812-817. PubMed ID: 30718202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Standardizing Scoring Conventions for Crohn's Disease Endoscopy: An International RAND/UCLA Appropriateness Study.
    Khanna R; Ma C; Hogan M; Zou G; Bessissow T; Bressler B; Colombel JF; Danese S; Daperno M; East JE; Hookey L; Loftus EV; McDonald JWD; Panaccione R; Peyrin-Biroulet L; Rutter M; Sands BE; Vermeire S; Rémillard J; McFarlane SC; Sandborn WJ; D'Haens GR; Feagan BG; Jairath V
    Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2938-2950.e6. PubMed ID: 37308036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of endoscopic response using pan-enteric capsule endoscopy in Crohn's disease; the Sensitivity to Change (STOC) study.
    Volkers A; Bossuyt P; de Jong J; Pouillon L; Gecse K; Duijvestein M; Ponsioen C; D'Haens G; Löwenberg M
    Scand J Gastroenterol; 2022 Apr; 57(4):439-445. PubMed ID: 34968158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoscopic evaluation of Crohn's disease activity: comparison of the CDEIS and the SES-CD.
    Sipponen T; Nuutinen H; Turunen U; Färkkilä M
    Inflamm Bowel Dis; 2010 Dec; 16(12):2131-6. PubMed ID: 20848462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.
    Dulai PS; Boland BS; Singh S; Chaudrey K; Koliani-Pace JL; Kochhar G; Parikh MP; Shmidt E; Hartke J; Chilukuri P; Meserve J; Whitehead D; Hirten R; Winters AC; Katta LG; Peerani F; Narula N; Sultan K; Swaminath A; Bohm M; Lukin D; Hudesman D; Chang JT; Rivera-Nieves J; Jairath V; Zou GY; Feagan BG; Shen B; Siegel CA; Loftus EV; Kane S; Sands BE; Colombel JF; Sandborn WJ; Lasch K; Cao C
    Gastroenterology; 2018 Sep; 155(3):687-695.e10. PubMed ID: 29857091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can balloon-assisted enteroscopy predict disease outcomes in patients with small-bowel Crohn's disease?
    Na JE; Hong SN; Kim JE; Kim ER; Kim YH; Chang DK
    BMC Gastroenterol; 2023 Sep; 23(1):331. PubMed ID: 37759282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Editorial: Endoscopic Scoring Systems in Crohn's Disease for Evaluation of Responsiveness to Treatment: Are we Ready for the Prime Time of Endoscopic Assessment?
    Buchner AM; Lichtenstein GR
    Am J Gastroenterol; 2017 Oct; 112(10):1593-1595. PubMed ID: 28978952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease.
    af Björkesten CG; Nieminen U; Turunen U; Arkkila P; Sipponen T; Färkkilä M
    Scand J Gastroenterol; 2012 May; 47(5):528-37. PubMed ID: 22356594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasonographic scores for ileal Crohn's disease assessment: Better, worse or the same as contrast-enhanced ultrasound?
    Freitas M; de Castro FD; Macedo Silva V; Arieira C; Cúrdia Gonçalves T; Leite S; Moreira MJ; Cotter J
    BMC Gastroenterol; 2022 May; 22(1):252. PubMed ID: 35585503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bowel ultrasound score is accurate in assessing response to therapy in patients with Crohn's disease.
    Allocca M; Craviotto V; Dell'Avalle C; Furfaro F; Zilli A; D'Amico F; Bonovas S; Peyrin-Biroulet L; Fiorino G; Danese S
    Aliment Pharmacol Ther; 2022 Feb; 55(4):446-454. PubMed ID: 34783066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease.
    Löwenberg M; Vermeire S; Mostafavi N; Hoentjen F; Franchimont D; Bossuyt P; Hindryckx P; Rispens T; de Vries A; van der Woude CJ; Berends S; Ambarus CA; Mathot R; Clasquin E; Baert F; D'Haens G
    Gastroenterology; 2019 Oct; 157(4):997-1006.e6. PubMed ID: 31175865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of double-balloon endoscopy and an endoscopic scoring system to assess endoscopic remission in isolated small bowel Crohn's disease after treatment with infliximab.
    Han W; Hu J; Wu J; Zhang P; Liu Q; Hu N; Mei Q
    Therap Adv Gastroenterol; 2024; 17():17562848231224842. PubMed ID: 38250016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation and concordance measures between clinical, endoscopic and histological scores activity in Crohn's disease under treatment.
    Tajra JB; Calegaro JU; de Paula AP; Bachour D; Silveira D; Lozi M; Cavalcanti H
    Scand J Gastroenterol; 2019 Apr; 54(4):441-445. PubMed ID: 30939952
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease.
    Rutgeerts P; Gasink C; Chan D; Lang Y; Pollack P; Colombel JF; Wolf DC; Jacobstein D; Johanns J; Szapary P; Adedokun OJ; Feagan BG; Sandborn WJ
    Gastroenterology; 2018 Oct; 155(4):1045-1058. PubMed ID: 29909019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Radiomics Model Integrating Luminal and Mesenteric Features to Predict Mucosal Activity and Surgery Risk in Crohn's Disease Patients: A Multicenter Study.
    Ruiqing L; Jing Y; Shunli L; Jia K; Zhibo W; Hongping Z; Keyu R; Xiaoming Z; Zhiming W; Weiming Z; Tianye N; Yun L
    Acad Radiol; 2023 Sep; 30 Suppl 1():S207-S219. PubMed ID: 37149448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.